Acute leukemias in children with Down syndrome.

Children with Down syndrome have an increased risk for developing both acute myeloid as well as lymphoblastic leukemia. These leukemias differ in presenting characteristics and underlying biology when compared with leukemias occurring in non-Down syndrome children. Myeloid leukemia in children with...

Full description

Bibliographic Details
Main Authors: Zwaan, C, Reinhardt, D, Hitzler, J, Vyas, P
Format: Journal article
Language:English
Published: 2010
_version_ 1797051659426201600
author Zwaan, C
Reinhardt, D
Hitzler, J
Vyas, P
author_facet Zwaan, C
Reinhardt, D
Hitzler, J
Vyas, P
author_sort Zwaan, C
collection OXFORD
description Children with Down syndrome have an increased risk for developing both acute myeloid as well as lymphoblastic leukemia. These leukemias differ in presenting characteristics and underlying biology when compared with leukemias occurring in non-Down syndrome children. Myeloid leukemia in children with Down syndrome is preceded by a preleukemic clone (transient leukemia or transient myeloproliferative disorder), which may disappear spontaneously, but may also need treatment in case of severe symptoms. Twenty percent of children with transient leukemia subsequently develop myeloid leukemia. This transition offers a unique model to study the stepwise development of leukemia and of gene dosage effects mediated by aneuploidy.
first_indexed 2024-03-06T18:22:42Z
format Journal article
id oxford-uuid:06dd2766-990b-4f36-9e88-018414c8648e
institution University of Oxford
language English
last_indexed 2024-03-06T18:22:42Z
publishDate 2010
record_format dspace
spelling oxford-uuid:06dd2766-990b-4f36-9e88-018414c8648e2022-03-26T09:04:34ZAcute leukemias in children with Down syndrome.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:06dd2766-990b-4f36-9e88-018414c8648eEnglishSymplectic Elements at Oxford2010Zwaan, CReinhardt, DHitzler, JVyas, PChildren with Down syndrome have an increased risk for developing both acute myeloid as well as lymphoblastic leukemia. These leukemias differ in presenting characteristics and underlying biology when compared with leukemias occurring in non-Down syndrome children. Myeloid leukemia in children with Down syndrome is preceded by a preleukemic clone (transient leukemia or transient myeloproliferative disorder), which may disappear spontaneously, but may also need treatment in case of severe symptoms. Twenty percent of children with transient leukemia subsequently develop myeloid leukemia. This transition offers a unique model to study the stepwise development of leukemia and of gene dosage effects mediated by aneuploidy.
spellingShingle Zwaan, C
Reinhardt, D
Hitzler, J
Vyas, P
Acute leukemias in children with Down syndrome.
title Acute leukemias in children with Down syndrome.
title_full Acute leukemias in children with Down syndrome.
title_fullStr Acute leukemias in children with Down syndrome.
title_full_unstemmed Acute leukemias in children with Down syndrome.
title_short Acute leukemias in children with Down syndrome.
title_sort acute leukemias in children with down syndrome
work_keys_str_mv AT zwaanc acuteleukemiasinchildrenwithdownsyndrome
AT reinhardtd acuteleukemiasinchildrenwithdownsyndrome
AT hitzlerj acuteleukemiasinchildrenwithdownsyndrome
AT vyasp acuteleukemiasinchildrenwithdownsyndrome